Amneal Pharmaceuticals (Germany) Investor Sentiment

2DT Stock  EUR 7.35  0.05  0.68%   
Roughly 61% of Amneal Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Amneal Pharmaceuticals suggests that many traders are alarmed regarding Amneal Pharmaceuticals' prospects. The current market sentiment, together with Amneal Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Amneal Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Amneal Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Amneal daily returns and investor perception about the current price of Amneal Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  
over two weeks ago at news.google.com         
Amneal Pharmaceuticals, Inc. Shares Sold by Jacobs Levy Equity Management Inc. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Walleye Capital LLC Invests 1.10 Million in Amneal Pharmaceuticals, Inc. - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Amneal Pharmaceuticals Leadership to Present at Major Healthcare Investment Conferences AMRX Stock N...
Google News at Macroaxis
over a month ago at news.google.com         
Amneal Pharmaceuticals director John Kiely sells 142,946 in stock - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
Amneal Pharmaceuticals exec sells shares worth 114,786 - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
GSA Capital Partners LLP Sells 100,410 Shares of Amneal Pharmaceuticals, Inc. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
AMNEAL PHARMACEUTICALS, INC. Hit a 52 Week High, Can the Run Continue - MSN
Google News at Macroaxis
over a month ago at news.google.com         
Phocas Financial Corp. Reduces Position in Amneal Pharmaceuticals, Inc. - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
AMNEAL PHARMACEUTICALS, INC. Hit a 52 Week High, Can the Run Continue - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
AMRX Stock Soars to 52-Week High, Reaching 8.97 Amid Growth - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
Revenues Working Against Amneal Pharmaceuticals, Inc.s Share Price - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
Amneal Pharma Q3 Revenue Surges 13 percent to 702M, Expands Drug Pipeline Despite EPS Dip AMRX Stock...
Google News at Macroaxis
over a month ago at news.google.com         
Earnings To Watch Amneal Pharmaceuticals Inc Reports Q3 2024 Result - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Earnings Preview Amneal Pharmaceuticals Q3 Earnings Expected to Decline - Yahoo Finance
Google News at Macroaxis
over two months ago at news.google.com         
Is Amneal Pharmaceuticals Outperforming Other Medical Stocks This Year - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Amneal Pharmaceuticals that are available to investors today. That information is available publicly through Amneal media outlets and privately through word of mouth or via Amneal internal channels. However, regardless of the origin, that massive amount of Amneal data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Amneal Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Amneal Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Amneal Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Amneal Pharmaceuticals alpha.

Amneal Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Amneal Stock analysis

When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
CEOs Directory
Screen CEOs from public companies around the world
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities